Polaris Logo - v2.png
Multiple Sclerosis Market Set to Reach USD 33.57 Billion by 2032, Growing at a CAGR of 5.4% | Polaris Market Research (PMR)
August 19, 2024 08:25 ET | Polaris Market Research & Consulting LLP
New York, USA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Market Overview: The multiple sclerosis market was estimated at USD 21.04 billion in 2023. The market valuation is expected to be USD 33.57 billion...
22157.jpg
Global Central Nervous System (CNS) Therapeutic Market Report, 2024: A Projected $215.19 Billion Opportunity by 2034 with with Asia-Pacific Gaining Momentum
June 27, 2024 09:57 ET | Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Central Nervous System Therapeutic Market" report has been added to ResearchAndMarkets.com's offering. The central nervous system (CNS)...
Logo.jpg
Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research
April 25, 2024 08:50 ET | DataHorizzon Research
Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized...
Final Logo-01.png
Multiple Sclerosis Market is estimated to be US$ 32.9 billion by 2032; Rising Early Diagnosis and Advancements in Treatment to Boost Market Growth – BY PMI
October 25, 2023 14:00 ET | PMI
Covina, Oct. 25, 2023 (GLOBE NEWSWIRE) -- What is multiple sclerosis, and how does it affect patients? Multiple Sclerosis is often categorized into different clinical forms. The most common...
SNS-INSIDER-300X300.jpg
Multiple Sclerosis (MS) Market to Cross USD 28.21 Billion by 2030 due to Rising Prevalence of Multiple Sclerosis (MS) and Favorable Reimbursement Policies | Research by SNS Insider
May 10, 2023 09:15 ET | SNS Insider pvt ltd
Pune, May 10, 2023 (GLOBE NEWSWIRE) -- “The Multiple Sclerosis (MS) Market was valued at USD 23.2 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 2.2% over the...
Global Neurological Biomarkers Market
Global Neurological Biomarkers Market Report 2022 to 2028: Featuring Bio-Rad Laboratories, Merck, PerkinElmer and Shimadzu Among Others
March 21, 2023 11:33 ET | Research and Markets
Dublin, March 21, 2023 (GLOBE NEWSWIRE) -- The "Global Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report by Type (Proteomic, Genomic, Metabolomic), Application...
mrf.jpg
Multiple Sclerosis Treatment Market Size to Surpass USD 30.55 Billion by 2030 at 2.31% CAGR – Report by Market Research Future (MRFR)
February 15, 2023 09:00 ET | Market Research Future
New York, USA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Multiple Sclerosis Treatment Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Multiple Sclerosis...
22157.jpg
Multiple Sclerosis Global Market Analysis: Historical Data 2016-2020 and Forecasts for 2021-2026
February 25, 2022 04:03 ET | Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights,...
22157.jpg
Global Multiple Sclerosis Industry Review 2018-2020 with Forecasts to 2026 - Market Size by Country, Competitor Drug Sales, Market Shares, and More
December 24, 2021 06:58 ET | Research and Markets
Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This report provides...
22157.jpg
Global Multiple Sclerosis Drugs Market Report 2021: Market is Expected to Reach $25.95 Billion in 2025 - Long-term Forecast to 2030
December 13, 2021 06:53 ET | Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...